MEDIFAST INC (MED)
Official siteCONSUMER CYCLICAL • PERSONAL SERVICES • NYSE
Market Cap: $145.04M
Last updated: Nov 17, 2026 at 11:06 AM ET
MEDIFAST INC (MED) Valuation Multiples
MEDIFAST INC (MED) trades at 0.5x sales and 0.8x book value. Its P/S of 0.5x is above its 5-year median of 0.4x. Its forward P/E is 12.5x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 12.5x |
| Price to sales | 0.5x |
| Price to book | 0.8x |
| PEG | N/A |
| FCF yield | -2.8% |
Historical Medians
Against its 10-year medians, its P/S is 66.7% below 1.5x and its P/B is 89.6% below 7.7x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | N/A | 7.9x | 17.1x |
| P/S | 0.5x | 0.4x | 1.5x |
| P/B | 0.8x | 1.4x | 7.7x |
Valuation History
Over the 9 of the 10 year ends shown that have a P/E, its P/E ranged from 7.4x in 2023 to 30.5x in 2017.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $10.68 | N/A | 0.3x | 0.6x |
| 2024 | $17.62 | 8.7x | 0.3x | 0.9x |
| 2023 | $67.22 | 7.4x | 0.7x | 3.6x |
| 2022 | $115.35 | 8.2x | 0.8x | 8.2x |
| 2021 | $209.43 | 15.1x | 1.6x | 12.2x |
| 2020 | $196.34 | 21.4x | 2.5x | 14.8x |
| 2019 | $109.58 | 17.0x | 1.8x | 12.5x |
| 2018 | $125.02 | 27.1x | 3.0x | 13.8x |
| 2017 | $69.81 | 30.5x | 2.8x | 7.8x |
| 2016 | $41.63 | 21.9x | 1.8x | 5.2x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MED
What is MED's forward P/E ratio?
MEDIFAST INC has a forward P/E ratio of 12.5x.
Is MED stock overvalued?
GNG's valuation label for MED is Fairly valued.
What is MED's price to sales ratio?
MEDIFAST INC has a price to sales ratio of 0.5x.
What is MEDIFAST INC's average P/E ratio over 5 years?
MEDIFAST INC's median P/E over the last 5 years is 7.9x, from 49 month-end values through Oct 2026.
MED pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors